VEGFA and myeloid sarcoma: VEGF is strongly expressed in inflammatory-active MS lesions [35, 40], its serum levels were found to be increased during relapses [44], and astrocyte-derived VEGF mediated a disruption of the BBB in animal models of the disease [3, 4].